1 Remdesivir (COVID-19) Market Overview 1.1 Remdesivir (COVID-19) Product Overview 1.2 Remdesivir (COVID-19) Market Segment by Type 1.2.1 5mg 1.2.2 10mg 1.2.3 50mg 1.2.4 100mg 1.3 Global Remdesivir (COVID-19) Market Size by Type 1.3.1 Global Remdesivir (COVID-19) Market Size Overview by Type (2016-2027) 1.3.2 Global Remdesivir (COVID-19) Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Remdesivir (COVID-19) Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Remdesivir (COVID-19) Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Remdesivir (COVID-19) Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Remdesivir (COVID-19) Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Remdesivir (COVID-19) Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Remdesivir (COVID-19) Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Remdesivir (COVID-19) Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Remdesivir (COVID-19) Sales Breakdown by Type (2016-2021) 1.4.2 Europe Remdesivir (COVID-19) Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Remdesivir (COVID-19) Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Remdesivir (COVID-19) Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Remdesivir (COVID-19) Sales Breakdown by Type (2016-2021) 2 Global Remdesivir (COVID-19) Market Competition by Company 2.1 Global Top Players by Remdesivir (COVID-19) Sales (2016-2021) 2.2 Global Top Players by Remdesivir (COVID-19) Revenue (2016-2021) 2.3 Global Top Players Remdesivir (COVID-19) Price (2016-2021) 2.4 Global Top Manufacturers Remdesivir (COVID-19) Manufacturing Base Distribution, Sales Area, Product Type 2.5 Remdesivir (COVID-19) Market Competitive Situation and Trends 2.5.1 Remdesivir (COVID-19) Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Remdesivir (COVID-19) Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Remdesivir (COVID-19) as of 2020) 2.7 Date of Key Manufacturers Enter into Remdesivir (COVID-19) Market 2.8 Key Manufacturers Remdesivir (COVID-19) Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Remdesivir (COVID-19) Status and Outlook by Region 3.1 Global Remdesivir (COVID-19) Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Remdesivir (COVID-19) Historic Market Size by Region 3.2.1 Global Remdesivir (COVID-19) Sales in Volume by Region (2016-2021) 3.2.2 Global Remdesivir (COVID-19) Sales in Value by Region (2016-2021) 3.2.3 Global Remdesivir (COVID-19) Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Remdesivir (COVID-19) Forecasted Market Size by Region 3.3.1 Global Remdesivir (COVID-19) Sales in Volume by Region (2022-2027) 3.3.2 Global Remdesivir (COVID-19) Sales in Value by Region (2022-2027) 3.3.3 Global Remdesivir (COVID-19) Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Remdesivir (COVID-19) by Application 4.1 Remdesivir (COVID-19) Market Segment by Application 4.1.1 Hospital 4.1.2 Clinics 4.1.3 Drug Store 4.1.4 Others 4.2 Global Remdesivir (COVID-19) Market Size by Application 4.2.1 Global Remdesivir (COVID-19) Market Size Overview by Application (2016-2027) 4.2.2 Global Remdesivir (COVID-19) Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Remdesivir (COVID-19) Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Remdesivir (COVID-19) Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Remdesivir (COVID-19) Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Remdesivir (COVID-19) Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Remdesivir (COVID-19) Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Remdesivir (COVID-19) Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Remdesivir (COVID-19) Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Remdesivir (COVID-19) Sales Breakdown by Application (2016-2021) 4.3.2 Europe Remdesivir (COVID-19) Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Remdesivir (COVID-19) Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Remdesivir (COVID-19) Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Remdesivir (COVID-19) Sales Breakdown by Application (2016-2021) 5 North America Remdesivir (COVID-19) by Country 5.1 North America Remdesivir (COVID-19) Historic Market Size by Country 5.1.1 North America Remdesivir (COVID-19) Sales in Volume by Country (2016-2021) 5.1.2 North America Remdesivir (COVID-19) Sales in Value by Country (2016-2021) 5.2 North America Remdesivir (COVID-19) Forecasted Market Size by Country 5.2.1 North America Remdesivir (COVID-19) Sales in Volume by Country (2022-2027) 5.2.2 North America Remdesivir (COVID-19) Sales in Value by Country (2022-2027) 6 Europe Remdesivir (COVID-19) by Country 6.1 Europe Remdesivir (COVID-19) Historic Market Size by Country 6.1.1 Europe Remdesivir (COVID-19) Sales in Volume by Country (2016-2021) 6.1.2 Europe Remdesivir (COVID-19) Sales in Value by Country (2016-2021) 6.2 Europe Remdesivir (COVID-19) Forecasted Market Size by Country 6.2.1 Europe Remdesivir (COVID-19) Sales in Volume by Country (2022-2027) 6.2.2 Europe Remdesivir (COVID-19) Sales in Value by Country (2022-2027) 7 Asia-Pacific Remdesivir (COVID-19) by Region 7.1 Asia-Pacific Remdesivir (COVID-19) Historic Market Size by Region 7.1.1 Asia-Pacific Remdesivir (COVID-19) Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Remdesivir (COVID-19) Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Remdesivir (COVID-19) Forecasted Market Size by Region 7.2.1 Asia-Pacific Remdesivir (COVID-19) Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Remdesivir (COVID-19) Sales in Value by Region (2022-2027) 8 Latin America Remdesivir (COVID-19) by Country 8.1 Latin America Remdesivir (COVID-19) Historic Market Size by Country 8.1.1 Latin America Remdesivir (COVID-19) Sales in Volume by Country (2016-2021) 8.1.2 Latin America Remdesivir (COVID-19) Sales in Value by Country (2016-2021) 8.2 Latin America Remdesivir (COVID-19) Forecasted Market Size by Country 8.2.1 Latin America Remdesivir (COVID-19) Sales in Volume by Country (2022-2027) 8.2.2 Latin America Remdesivir (COVID-19) Sales in Value by Country (2022-2027) 9 Middle East and Africa Remdesivir (COVID-19) by Country 9.1 Middle East and Africa Remdesivir (COVID-19) Historic Market Size by Country 9.1.1 Middle East and Africa Remdesivir (COVID-19) Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Remdesivir (COVID-19) Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Remdesivir (COVID-19) Forecasted Market Size by Country 9.2.1 Middle East and Africa Remdesivir (COVID-19) Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Remdesivir (COVID-19) Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Remdesivir (COVID-19) Business 10.1 Gilead Sciences 10.1.1 Gilead Sciences Corporation Information 10.1.2 Gilead Sciences Introduction and Business Overview 10.1.3 Gilead Sciences Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Gilead Sciences Remdesivir (COVID-19) Products Offered 10.1.5 Gilead Sciences Recent Development 10.2 Bright Gene 10.2.1 Bright Gene Corporation Information 10.2.2 Bright Gene Introduction and Business Overview 10.2.3 Bright Gene Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Gilead Sciences Remdesivir (COVID-19) Products Offered 10.2.5 Bright Gene Recent Development 10.3 Hainan Haiyao 10.3.1 Hainan Haiyao Corporation Information 10.3.2 Hainan Haiyao Introduction and Business Overview 10.3.3 Hainan Haiyao Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Hainan Haiyao Remdesivir (COVID-19) Products Offered 10.3.5 Hainan Haiyao Recent Development 10.4 Kelun Pharma 10.4.1 Kelun Pharma Corporation Information 10.4.2 Kelun Pharma Introduction and Business Overview 10.4.3 Kelun Pharma Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Kelun Pharma Remdesivir (COVID-19) Products Offered 10.4.5 Kelun Pharma Recent Development 10.5 Hunan Warrant Pharmaceutical 10.5.1 Hunan Warrant Pharmaceutical Corporation Information 10.5.2 Hunan Warrant Pharmaceutical Introduction and Business Overview 10.5.3 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Products Offered 10.5.5 Hunan Warrant Pharmaceutical Recent Development 10.6 Borui Bio-Pharmaceutical 10.6.1 Borui Bio-Pharmaceutical Corporation Information 10.6.2 Borui Bio-Pharmaceutical Introduction and Business Overview 10.6.3 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Products Offered 10.6.5 Borui Bio-Pharmaceutical Recent Development 10.7 Berry Global Group 10.7.1 Berry Global Group Corporation Information 10.7.2 Berry Global Group Introduction and Business Overview 10.7.3 Berry Global Group Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021) 10.7.4 Berry Global Group Remdesivir (COVID-19) Products Offered 10.7.5 Berry Global Group Recent Development 10.8 Inovio Pharmaceuticals 10.8.1 Inovio Pharmaceuticals Corporation Information 10.8.2 Inovio Pharmaceuticals Introduction and Business Overview 10.8.3 Inovio Pharmaceuticals Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021) 10.8.4 Inovio Pharmaceuticals Remdesivir (COVID-19) Products Offered 10.8.5 Inovio Pharmaceuticals Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Remdesivir (COVID-19) Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Remdesivir (COVID-19) Industrial Chain Analysis 11.4 Remdesivir (COVID-19) Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Remdesivir (COVID-19) Distributors 12.3 Remdesivir (COVID-19) Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of 5mg Table 2. Major Company of 10mg Table 3. Major Company of 50mg Table 4. Major Company of 100mg Table 5. Global Remdesivir (COVID-19) Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 6. Global Remdesivir (COVID-19) Sales by Type (2016-2021) & (K Units) Table 7. Global Remdesivir (COVID-19) Sales Market Share in Volume by Type (2016-2021) Table 8. Global Remdesivir (COVID-19) Sales by Type (2016-2021) & (US& Million) Table 9. Global Remdesivir (COVID-19) Market Share in Value by Type (2016-2021) Table 10. Global Remdesivir (COVID-19) Price by Type (2016-2021) & (US$/Unit) Table 11. Global Remdesivir (COVID-19) Sales by Type (2022-2027) & (K Units) Table 12. Global Remdesivir (COVID-19) Sales Market Share in Volume by Type (2022-2027) Table 13. Global Remdesivir (COVID-19) Sales by Type (2022-2027) & (US$ Million) Table 14. Global Remdesivir (COVID-19) Sales Market Share in Value by Type (2022-2027) Table 15. Global Remdesivir (COVID-19) Price by Type (2022-2027) & (US$/Unit) Table 16. North America Remdesivir (COVID-19) Sales by Type (2016-2021) & (K Units) Table 17. North America Remdesivir (COVID-19) Sales by Type (2016-2021) & (US$ Million) Table 18. Europe Remdesivir (COVID-19) Sales (K Units) by Type (2016-2021) Table 19. Europe Remdesivir (COVID-19) Sales by Type (2016-2021) & (US$ Million) Table 20. Asia-Pacific Remdesivir (COVID-19) Sales (K Units) by Type (2016-2021) Table 21. Asia-Pacific Remdesivir (COVID-19) Sales by Type (2016-2021) & (US$ Million) Table 22. Latin America Remdesivir (COVID-19) Sales (K Units) by Type (2016-2021) Table 23. Latin America Remdesivir (COVID-19) Sales by Type (2016-2021) & (US$ Million) Table 24. Middle East and Africa Remdesivir (COVID-19) Sales (K Units) by Type (2016-2021) Table 25. Middle East and Africa Remdesivir (COVID-19) Sales by Type (2016-2021) & (US$ Million) Table 26. Global Remdesivir (COVID-19) Sales by Company (2016-2021) & (K Units) Table 27. Global Remdesivir (COVID-19) Sales Share by Company (2016-2021) Table 28. Global Remdesivir (COVID-19) Revenue by Company (2016-2021) & (US$ Million) Table 29. Global Remdesivir (COVID-19) Revenue Share by Company (2016-2021) Table 30. Global Market Remdesivir (COVID-19) Price by Company (2016-2021) & (US$/Unit) Table 31. Global Remdesivir (COVID-19) Top Manufacturers Manufacturing Base Distribution and Sales Area Table 32. Global Remdesivir (COVID-19) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Remdesivir (COVID-19) as of 2020 Table 34. Date of Key Manufacturers Enter into Remdesivir (COVID-19) Market Table 35. Key Manufacturers Remdesivir (COVID-19) Product Type Table 36. Mergers & Acquisitions, Expansion Plans Table 37. Global Remdesivir (COVID-19) Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 38. Global Remdesivir (COVID-19) Sales by Region (2016-2021) & (K Units) Table 39. Global Remdesivir (COVID-19) Sales Market Share in Volume by Region (2016-2021) Table 40. Global Remdesivir (COVID-19) Sales by Region (2016-2021) & (US$ Million) Table 41. Global Remdesivir (COVID-19) Sales Market Share in Value by Region (2016-2021) Table 42. Global Remdesivir (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 43. Global Remdesivir (COVID-19) Sales by Region (2022-2027) & (K Units) Table 44. Global Remdesivir (COVID-19) Sales Market Share in Volume by Region (2022-2027) Table 45. Global Remdesivir (COVID-19) Sales by Region (2022-2027) & (US$ Million) Table 46. Global Remdesivir (COVID-19) Sales Market Share in Value by Region (2022-2027) Table 47. Global Remdesivir (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2022-2027) Table 48. Global Remdesivir (COVID-19) Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 49. Global Remdesivir (COVID-19) Sales by Application (2016-2021) & (K Units) Table 50. Global Remdesivir (COVID-19) Sales Market Share in Volume by Application (2016-2021) Table 51. Global Remdesivir (COVID-19) Sales by Application (2016-2021) & (US$ Million) Table 52. Global Remdesivir (COVID-19) Sales Market Share in Value by Application (2016-2021) Table 53. Global Remdesivir (COVID-19) Price by Application (2016-2021) & (US$/Unit) Table 54. Global Remdesivir (COVID-19) Sales by Application (2022-2027) & (K Units) Table 55. Global Remdesivir (COVID-19) Sales Market Share in Volume by Application (2022-2027) Table 56. Global Remdesivir (COVID-19) Sales by Application (2022-2027) & (US$ Million) Table 57. Global Remdesivir (COVID-19) Sales Market Share in Value by Application (2022-2027) Table 58. Global Remdesivir (COVID-19) Price by Application (2022-2027) & (US$/Unit) Table 59. North America Remdesivir (COVID-19) Sales by Application (2016-2021) (K Units) Table 60. North America Remdesivir (COVID-19) Sales by Application (2016-2021) & (US$ Million) Table 61. North America Remdesivir (COVID-19) Sales Market Share in Value by Application in 2020 Table 62. Europe Remdesivir (COVID-19) Sales by Application (2016-2021) (K Units) Table 63. Europe Remdesivir (COVID-19) Sales by Application (2016-2021) & (US$ Million) Table 64. Europe Remdesivir (COVID-19) Sales Market Share in Value by Application in 2020 Table 65. Asia-Pacific Remdesivir (COVID-19) Sales by Application (2016-2021) (K Units) Table 66. Asia-Pacific Remdesivir (COVID-19) Sales by Application (2016-2021) & (US$ Million) Table 67. Asia-Pacific Remdesivir (COVID-19) Sales Market Share in Value by Application in 2020 Table 68. Latin America Remdesivir (COVID-19) Sales by Application (2016-2021) (K Units) Table 69. Latin America Remdesivir (COVID-19) Sales by Application (2016-2021) & (US$ Million) Table 70. Latin America Remdesivir (COVID-19) Sales Market Share in Value by Application in 2020 Table 71. Middle East and Africa Remdesivir (COVID-19) Sales by Application (2016-2021) (K Units) Table 72. Middle East and Africa Remdesivir (COVID-19) Sales by Application (2016-2021) & (US$ Million) Table 73. Middle East and Africa Remdesivir (COVID-19) Sales Market Share in Value by Application in 2020 Table 74. North America Remdesivir (COVID-19) Sales by Country (2016-2021) & (K Units) Table 75. North America Remdesivir (COVID-19) Sales Market Share in Volume by Country (2016-2021) Table 76. North America Remdesivir (COVID-19) Sales by Country (2016-2021) & (US$ Million) Table 77. North America Remdesivir (COVID-19) Sales Market Share in Value by Country (2016-2021) Table 78. North America Remdesivir (COVID-19) Sales by Country (2022-2027) & (K Units) Table 79. North America Remdesivir (COVID-19) Sales Market Share in Volume by Country (2022-2027) Table 80. North America Remdesivir (COVID-19) Sales by Country (2022-2027) & (US$ Million) Table 81. North America Remdesivir (COVID-19) Sales Market Share in Value by Country (2022-2027) Table 82. Europe Remdesivir (COVID-19) Sales by Country (2016-2021) & (K Units) Table 83. Europe Remdesivir (COVID-19) Sales Market Share in Volume by Country (2016-2021) Table 84. Europe Remdesivir (COVID-19) Sales by Country (2016-2021) & (US$ Million) Table 85. Europe Remdesivir (COVID-19) Sales Market Share in Value by Country (2016-2021) Table 86. Europe Remdesivir (COVID-19) Sales by Country (2022-2027) & (K Units) Table 87. Europe Remdesivir (COVID-19) Sales Market Share in Volume by Country (2022-2027) Table 88. Europe Remdesivir (COVID-19) Sales by Country (2022-2027) & (US$ Million) Table 89. Europe Remdesivir (COVID-19) Sales Market Share in Value by Country (2022-2027) Table 90. Asia-Pacific Remdesivir (COVID-19) Sales by Region (2016-2021) & (K Units) Table 91. Asia-Pacific Remdesivir (COVID-19) Sales Market Share in Volume by Region (2016-2021) Table 92. Asia-Pacific Remdesivir (COVID-19) Sales by Region (2016-2021) & (US$ Million) Table 93. Asia-Pacific Remdesivir (COVID-19) Sales Market Share in Value by Region (2016-2021) Table 94. Asia-Pacific Remdesivir (COVID-19) Sales by Region (2022-2027) & (K Units) Table 95. Asia-Pacific Remdesivir (COVID-19) Sales Market Share in Volume by Region (2022-2027) Table 96. Asia-Pacific Remdesivir (COVID-19) Sales by Region (2022-2027) & (US$ Million) Table 97. Asia-Pacific Remdesivir (COVID-19) Sales Market Share in Value by Region (2022-2027) Table 98. Latin America Remdesivir (COVID-19) Sales by Country (2016-2021) & (K Units) Table 99. Latin America Remdesivir (COVID-19) Sales Market Share in Volume by Country (2016-2021) Table 100. Latin America Remdesivir (COVID-19) Sales by Country (2016-2021) & (US$ Million) Table 101. Latin America Remdesivir (COVID-19) Sales Market Share in Value by Country (2016-2021) Table 102. Latin America Remdesivir (COVID-19) Sales by Country (2022-2027) & (K Units) Table 103. Latin America Remdesivir (COVID-19) Sales Market Share in Volume by Country (2022-2027) Table 104. Latin America Remdesivir (COVID-19) Sales by Country (2022-2027) & (US$ Million) Table 105. Latin America Remdesivir (COVID-19) Sales Market Share in Value by Country (2022-2027) Table 106. Middle East and Africa Remdesivir (COVID-19) Sales by Country (2016-2021) & (K Units) Table 107. Middle East and Africa Remdesivir (COVID-19) Sales Market Share in Volume by Country (2016-2021) Table 108. Middle East and Africa Remdesivir (COVID-19) Sales by Country (2016-2021) & (US$ Million) Table 109. Middle East and Africa Remdesivir (COVID-19) Sales Market Share in Value by Country (2016-2021) Table 110. Middle East and Africa Remdesivir (COVID-19) Sales by Country (2022-2027) & (K Units) Table 111. Middle East and Africa Remdesivir (COVID-19) Sales Market Share in Volume by Country (2022-2027) Table 112. Middle East and Africa Remdesivir (COVID-19) Sales by Country (2022-2027) & (US$ Million) Table 113. Middle East and Africa Remdesivir (COVID-19) Sales Market Share in Value by Country (2022-2027) Table 114. Gilead Sciences Corporation Information Table 115. Gilead Sciences Introduction and Business Overview Table 116. Gilead Sciences Remdesivir (COVID-19) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 117. Gilead Sciences Remdesivir (COVID-19) Product Table 118. Gilead Sciences Recent Development Table 119. Bright Gene Corporation Information Table 120. Bright Gene Introduction and Business Overview Table 121. Bright Gene Remdesivir (COVID-19) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 122. Bright Gene Remdesivir (COVID-19) Product Table 123. Bright Gene Recent Development Table 124. Hainan Haiyao Corporation Information Table 125. Hainan Haiyao Introduction and Business Overview Table 126. Hainan Haiyao Remdesivir (COVID-19) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 127. Hainan Haiyao Remdesivir (COVID-19) Product Table 128. Hainan Haiyao Recent Development Table 129. Kelun Pharma Corporation Information Table 130. Kelun Pharma Introduction and Business Overview Table 131. Kelun Pharma Remdesivir (COVID-19) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 132. Kelun Pharma Remdesivir (COVID-19) Product Table 133. Kelun Pharma Recent Development Table 134. Hunan Warrant Pharmaceutical Corporation Information Table 135. Hunan Warrant Pharmaceutical Introduction and Business Overview Table 136. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 137. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Product Table 138. Hunan Warrant Pharmaceutical Recent Development Table 139. Borui Bio-Pharmaceutical Corporation Information Table 140. Borui Bio-Pharmaceutical Introduction and Business Overview Table 141. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 142. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Product Table 143. Borui Bio-Pharmaceutical Recent Development Table 144. Berry Global Group Corporation Information Table 145. Berry Global Group Introduction and Business Overview Table 146. Berry Global Group Remdesivir (COVID-19) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 147. Berry Global Group Remdesivir (COVID-19) Product Table 148. Berry Global Group Recent Development Table 149. Inovio Pharmaceuticals Corporation Information Table 150. Inovio Pharmaceuticals Introduction and Business Overview Table 151. Inovio Pharmaceuticals Remdesivir (COVID-19) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 152. Inovio Pharmaceuticals Remdesivir (COVID-19) Product Table 153. Inovio Pharmaceuticals Recent Development Table 154. Key Raw Materials Lists Table 155. Raw Materials Key Suppliers Lists Table 156. Remdesivir (COVID-19) Market Trends Table 157. Remdesivir (COVID-19) Market Drivers Table 158. Remdesivir (COVID-19) Market Challenges Table 159. Remdesivir (COVID-19) Market Restraints Table 160. Remdesivir (COVID-19) Distributors List Table 161. Remdesivir (COVID-19) Downstream Customers Table 162. Research Programs/Design for This Report Table 163. Key Data Information from Secondary Sources Table 164. Key Data Information from Primary Sources List of Figures Figure 1. Remdesivir (COVID-19) Product Picture Figure 2. Global Remdesivir (COVID-19) Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Remdesivir (COVID-19) Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Remdesivir (COVID-19) Sales Status and Outlook (2016-2027) & (K Units) Figure 5. Product Picture of 5mg Figure 6. Global 5mg Sales YoY Growth (2016-2021) & (K Units) Figure 7. Product Picture of 10mg Figure 8. Global 10mg Sales YoY Growth (2016-2021) & (K Units) Figure 9. Product Picture of 50mg Figure 10. Global 50mg Sales YoY Growth (2016-2021) & (K Units) Figure 11. Product Picture of 100mg Figure 12. Global 100mg Sales YoY Growth (2016-2021) & (K Units) Figure 13. Global Remdesivir (COVID-19) Sales by Type (2016-2027) & (US$ Million) Figure 14. Global Remdesivir (COVID-19) Sales Market Share in Volume by Type (2016-2021) Figure 15. Global Remdesivir (COVID-19) Sales Market Share in Value by Type (2016-2021) Figure 16. Global Remdesivir (COVID-19) Sales Market Share in Volume by Type (2022-2027) Figure 17. Global Remdesivir (COVID-19) Sales Market Share in Value by Type (2022-2027) Figure 18. North America Remdesivir (COVID-19) Sales Market Share in Volume by Type in 2020 Figure 19. North America Remdesivir (COVID-19) Sales Market Share in Value by Type in 2020 Figure 20. Europe Remdesivir (COVID-19) Sales Market Share in Volume by Type in 2020 Figure 21. Europe Remdesivir (COVID-19) Sales Market Share in Value by Type in 2020 Figure 22. Asia-Pacific Remdesivir (COVID-19) Sales Market Share in Volume by Type in 2020 Figure 23. Asia-Pacific Remdesivir (COVID-19) Sales Market Share in Value by Type in 2020 Figure 24. Latin America Remdesivir (COVID-19) Sales Market Share in Volume by Type in 2020 Figure 25. Latin America Remdesivir (COVID-19) Sales Market Share in Value by Type in 2020 Figure 26. Middle East and Africa Remdesivir (COVID-19) Sales Market Share in Volume by Type in 2020 Figure 27. Middle East and Africa Remdesivir (COVID-19) Sales Market Share in Value by Type in 2020 Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Remdesivir (COVID-19) Sales in 2020 Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Remdesivir (COVID-19) Revenue in 2020 Figure 30. Remdesivir (COVID-19) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 31. Product Picture of Hospital Figure 32. Global Hospital Sales YoY Growth (2016-2027) & (K Units) Figure 33. Product Picture of Clinics Figure 34. Global Clinics Sales YoY Growth (2016-2027) & (K Units) Figure 35. Product Picture of Drug Store Figure 36. Global Drug Store Sales YoY Growth (2016-2027) & (K Units) Figure 37. Product Picture of Others Figure 38. Global Others Sales YoY Growth (2016-2027) & (K Units) Figure 39. Global Remdesivir (COVID-19) Sales by Application (2016-2027) & (US$ Million) Figure 40. Global Remdesivir (COVID-19) Sales Market Share in Volume by Application (2016-2021) Figure 41. Global Remdesivir (COVID-19) Sales Market Share in Value by Application (2016-2021) Figure 42. Global Remdesivir (COVID-19) Sales Market Share in Volume by Application (2022-2027) Figure 43. North America Remdesivir (COVID-19) Sales Market Share in Volume by Application in 2020 Figure 44. Latin America Remdesivir (COVID-19) Sales Market Share in Value by Application in 2020 Figure 45. Middle East and Africa Remdesivir (COVID-19) Sales Market Share in Value by Application in 2020 Figure 46. Key Raw Materials Price Figure 47. Remdesivir (COVID-19) Manufacturing Cost Structure Figure 48. Remdesivir (COVID-19) Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Gilead Sciences Bright Gene Hainan Haiyao Kelun Pharma Hunan Warrant Pharmaceutical Borui Bio-Pharmaceutical Berry Global Group Inovio Pharmaceuticals